Chronic Hepatitis C Infection — Noninvasive assessment of Liver Fibrosis in the era of Direct Acting Antivirals

Significant advancements in the diagnosis and treatment of chronic hepatitis C infection and its associated fibrosis have revolutionized treatment of these patients over the last several years. Liver biopsy, the gold standard diagnostic method for evaluating liver fibrosis level, was routinely used prior to initiation of hepatitis C therapy, placing patients at an inherent risk of adverse events. The recent advent of noninvasive serologic and nonserologic measures of hepatic fibrosis level has reduced the need for liver biopsy significantly, thereby minimizing its associated risks.

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2Qpaj2Z
via IFTTT